The EIPOD 4 programme underlines EMBL’s strong commitment to promoting interdisciplinary research. The institution has a long-standing tradition of scientific excellence that builds on highly interactive research between EMBL group leaders from different research units.
EIPOD projects capitalise on synergies emerging at the borders of overlapping yet separate scientific fields, and involve transferring techniques to a novel context. The programme is open to all nationalities and offers about 20 positions annually.
The EMBL-EBI and the Wellcome Trust Sanger Institute share the Wellcome Trust Genome Campus in Hinxton close to Cambridge. The two institutes have joined forces to offer postdoctoral fellowships focusing on projects that combine experimental (wet-lab) and computational (dry-lab) approaches.
Candidates are invited to put forth projects of their choice involving one group at each of the two institutes or may chose from a list of projects available at the beginning of each call. ESPOD fellows receive 3 year contracts and are jointly supervised by one faculty member from each of the two institutes.
EMBL‐EBI and the NIHR Cambridge Biomedical Research Centre (BRC) jointly offer a postdoctoral programme that builds on the collaborative relationship between the two institutes, supporting projects that apply computational approaches to translational clinical research involving human subjects. EBPOD postdoctoral fellows will be appointed for three years to work on projects under the joint supervision of faculty members from EMBL‐EBI and the Cambridge BRC.
The ETPOD programme leverages the expertise of EMBL Rome, EMBL-EBI and the Italian Institute of Technology (IIT) in the fields of neuroscience, epigenetics, genomics, and nanotechnology.
ETPOD fellows receive three year contracts to carry out research projects between a laboratory at IIT and a laboratory at either EMBL Rome or EMBL-EBI. Three-way collaborations between the institutions are also possible. The research should take advantage of complementary expertise from the participating laboratories.